CN104922614A - 一种中药褥疮膏 - Google Patents
一种中药褥疮膏 Download PDFInfo
- Publication number
- CN104922614A CN104922614A CN201510433552.6A CN201510433552A CN104922614A CN 104922614 A CN104922614 A CN 104922614A CN 201510433552 A CN201510433552 A CN 201510433552A CN 104922614 A CN104922614 A CN 104922614A
- Authority
- CN
- China
- Prior art keywords
- bed sore
- band bed
- chinese medicine
- sore ointment
- grass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000004210 Pressure Ulcer Diseases 0.000 title claims abstract description 59
- 239000002674 ointment Substances 0.000 title claims abstract description 56
- 239000003814 drug Substances 0.000 title claims abstract description 38
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 23
- 241000255791 Bombyx Species 0.000 claims abstract description 23
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 23
- 239000004863 Frankincense Substances 0.000 claims abstract description 22
- 241000628997 Flos Species 0.000 claims description 45
- 239000007766 cera flava Substances 0.000 claims description 26
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 24
- 241000180649 Panax notoginseng Species 0.000 claims description 24
- 241001161070 Calomela Species 0.000 claims description 22
- 241000717739 Boswellia sacra Species 0.000 claims description 21
- 230000000694 effects Effects 0.000 abstract description 28
- 208000002193 Pain Diseases 0.000 abstract description 17
- 230000036407 pain Effects 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 238000005469 granulation Methods 0.000 abstract description 6
- 230000003179 granulation Effects 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 4
- 230000001338 necrotic effect Effects 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000171022 Peltophorum pterocarpum Species 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 229940075397 calomel Drugs 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 208000025865 Ulcer Diseases 0.000 description 15
- 231100000397 ulcer Toxicity 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 12
- 239000003440 toxic substance Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 230000008961 swelling Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000014674 injury Diseases 0.000 description 6
- 238000012913 prioritisation Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 210000004394 hip joint Anatomy 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- VQLYBLABXAHUDN-UHFFFAOYSA-N bis(4-fluorophenyl)-methyl-(1,2,4-triazol-1-ylmethyl)silane;methyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1.C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 VQLYBLABXAHUDN-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种中药褥疮膏,包括野菊花10-20g、地丁草10-20g、草河车10-20g、红花10-20g、僵蚕草5-15g、银珠5-15g、姜黄5-15g、补骨脂5-15g、乳香5-15g、冰片5-15g、蜂房3-7g、蝉衣5-15g、甘草5-15g、半枝莲5-15g、轻粉2-8g、连翘5-15g、三七5-15g、青黛3-7g、黄蜡30-50g。诸药配伍精良,组方合理,共奏解毒消肿、清热透邪、去腐生肌,消炎散结等功效,不仅保护了人体重要器官,促进了坏死组织液化脱落,帮助新生组织迅速原位生长康复。同时也避免了手术和长期用药之苦,为褥疮患者减轻了痛苦,该药系纯中药制剂,疗效确切,安全可靠,无任何毒副作用,生产工艺简单,容易操作,值得推广和应用。
Description
技术领域
本发明涉及中药领域,具体地说,是涉及一种褥疮膏。
背景技术
褥疮又称压疮,压力性溃疡,是由于局部组织长期受压,发声持续缺血、缺氧、营养不良而致组织溃烂坏死。褥疮,是临床最常见的并发症之一,常见于脑卒中、脑外伤、骨折等长期卧床者,尤其是老年患者。目前医院发病率为3%-14%,病程发展迅速,难以治愈,治愈后极易复发。久治不愈的褥疮可并发骨髓炎、败血症和低蛋白血症等老年病人致死性病症。
目前,褥疮还没特效疗法,主要是要加强护理,定时翻身,局部减压,促进局部的血液循环。另外,在患处涂龙胆紫药水,存在用药时间长,效果不明显等缺陷,因此褥疮成为护理工作中一大难题。
发明内容
本发明要解决的技术问题是克服上述缺陷,提供一种疗效明显,能快速止痛、毒副作用小的中药褥疮膏。
为解决上述问题,本发明所采用的技术方案是:
一种中药褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花10-20g、地丁草10-20g、草河车10-20g、红花10-20g、僵蚕草5-15g、银珠5-15g、姜黄5-15g、补骨脂5-15g、乳香5-15g、冰片5-15g、蜂房3-7g、蝉衣5-15g、甘草5-15g、半枝莲5-15g、轻粉2-8g、连翘5-15g、三七5-15g、青黛3-7g、黄蜡30-50g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花10g、地丁草10g、草河车10g、红花10g、僵蚕草5g、银珠5g、姜黄5g、补骨脂5g、乳香5g、冰片5g、蜂房3g、蝉衣5g、甘草5g、半枝莲5g、轻粉2g、连翘5g、三七5g、青黛3g、黄蜡30g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花12g、地丁草12g、草河车12g、红花12g、僵蚕草7g、银珠7g、姜黄7g、补骨脂7g、乳香7g、冰片7g、蜂房3g、蝉衣7g、甘草7g、半枝莲7g、轻粉3g、连翘7g、三七7g、青黛3g、黄蜡34g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花14g、地丁草14g、草河车14g、红花14g、僵蚕草9g、银珠9g、姜黄9g、补骨脂9g、乳香9g、冰片9g、蜂房4g、蝉衣9g、甘草9g、半枝莲9g、轻粉4g、连翘9g、三七9g、青黛4g、黄蜡38g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花16g、地丁草16g、草河车16g、红花16g、僵蚕草11g、银珠11g、姜黄11g、补骨脂11g、乳香11g、冰片11g、蜂房5g、蝉衣11g、甘草11g、半枝莲11g、轻粉5g、连翘11g、三七11g、青黛5g、黄蜡42g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花18g、地丁草18g、草河车18g、红花18g、僵蚕草13g、银珠13g、姜黄13g、补骨脂13g、乳香13g、冰片13g、蜂房6g、蝉衣13g、甘草13g、半枝莲13g、轻粉6g、连翘13g、三七13g、青黛6g、黄蜡46g。
作为一种优化方案,所述褥疮膏包括以下组分:
野菊花20g、地丁草20g、草河车20g、红花20g、僵蚕草15g、银珠15g、姜黄15g、补骨脂15g、乳香15g、冰片15g、蜂房7g、蝉衣15g、甘草15g、半枝莲15g、轻粉8g、连翘15g、三七15g、青黛7g、黄蜡50g。
本发明中药褥疮膏的制备方法为:
其制备方法是将蜂腊250g、石腊895g倒入容器中,将上述重量的药物浸入10000毫升色拉油内,浸3天。用文火逐渐加热至沸腾,沸腾30分钟后,停止加热30分钟,此方法再重复循环两次,待药温降至70度左右,用多层消毒纱布滤过,将滤液倒入装有蜂腊、石腊的容器中使之溶解,至药温达到40摄氏度时进行分装,包装可50g-250g/瓶,即可待用。
本发明褥疮膏的使用方法为:
将褥疮创面用0.1%利凡诺尔冲洗消毒,再用生理盐水冲洗创面,创面若有坏死组织可根据情况适当予以剪除,以不出血为度。创面消毒切记冲洗、冲洗、再冲洗。消毒完毕,在创面上覆盖一层消毒纱布,在其上面涂褥疮软膏1-2mm厚度,外用消毒纱布6-8层包裹,再用绷带包扎固定,每日换药一次至痊愈。
本发明褥疮膏中:
野菊花,药性比较平实,具有清除湿热解除毒素、消肿止痛的功效,对金黄色葡萄球菌、白喉杆菌、链球菌、绿脓杆菌、蒺疾杆菌、流感病毒,均有抑制作用。主治疔疮,痈疽,丹毒,湿疹,皮炎等。
地丁草,其性寒味微苦,清热解毒,凉血消肿。主治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎;外敷治跌打损伤、痈肿、毒蛇咬伤等。
草河车,能清热解毒,消肿止痛,凉肝定惊。主治疔肿痈肿、咽喉肿痛、毒蛇咬伤、跌扑伤痛、惊风抽搐。
僵蚕草,味咸、辛,性平;具有熄风止痉,祛风止痛,祛风止痒,化痰散结之功效。
银珠,味辛、性温,能攻毒,杀虫,燥湿,劫痰。主治疥癣恶疮,痧气心腹痛。《纲目》记载:"银朱:破积滞,劫痰涎,散结胸,疗疥癣恶疮,杀虫及虱,功同粉霜。
姜黄,具有破血行气,通经止痛之功效。姜黄具有来源广泛、价格低廉、安全性高、无毒、副作用小等优点,在皮肤科具有广泛的应用价值。还能吸收紫外线,促进皮肤再生,对治疗烧伤、烫伤、皮肤溃疡也有一定疗效。从姜黄中提取的挥发油具有独一无二的芬芳特性,其中所含有的姜黄素(curcumin)可抑制超氧化物生成,从而降低H2O2引起细胞毒性,对人角化细胞起保护作用;能明显降低人体面部皮肤的粗糙度,是延缓皮肤衰老的有效药物。
补骨脂,性味辛,苦,大温。能促进皮肤色素新生,具有活血助阳,光敏生色的作用。主治白癜风,银屑病,硬皮病,扁平疣等。
蝉衣,味甘,性寒;归肝、肺经。具有散风热、宣肺、定痉之功效。用于外感风热、发热恶寒、咳嗽,以及风疹、皮肤瘙痒等症。用于风热表症常配合薄荷等同用;对风疹瘙痒也有祛风止痒的功能。
甘草有解毒、祛痰、止痛、解痉以至抗癌等药理作用。甘草还有抗炎,抗过敏作用,能保护发炎的咽喉和气管粘膜。甘草浸膏和甘草酸对某些毒物有类似葡萄糖醛酸的解毒作用。其性能缓急,而又协和诸药,使之不争,故热药得之缓其热,寒药得之缓其寒,寒热相杂者,用之得其平。
半枝莲,味辛、苦,寒;归肺、肝、肾经。具有清热解毒,化瘀利尿之功效。
三七,味甘、微苦,性温;具有散瘀止血,消肿定痛的功效,主要用于咯血、吐血、衄血、便血、崩漏、外伤出血、胸腹刺痛、跌打肿痛等病症。
青黛,味咸,性寒;归肝经。具有清热解毒,凉血定惊之功效。外敷可治疮疡,痄腮。
黄蜡,具有解毒、生肌、止痢、止血、定痛等功效。主治痈疽发背,溃疡为敛;急心痛;下痢脓血;久泻不止。
红花有活血通经、散瘀止痛的功效,用于症瘕痞块、跌打损伤,适用各种静脉曲张、末梢神经炎、血液循环、腿脚麻木或青紫等淤血症。
乳香有调气活血、定痛、追毒的功效,治痈疮肿毒、跌打损伤。
冰片有开窍醒神、清热止痛的功效,可通诸窍、散郁火、去翳明目、消肿止痛,治痈肿、痔疮。
蜂房有祛风、攻毒、杀虫、止痛、抗过敏的功效,治疮疡肿毒、乳痈、瘰疬、皮肤顽癣、鹅掌风、过敏性体质。
轻粉有杀虫、攻毒、利水、通便的功效,治疥癣、瘰疬、下疳、皮肤溃疡、水肿、臌胀。
连翘有清热解毒、散结消肿的功效,治斑疹、丹毒、瘰疬、痈疮肿毒。
方中,野菊花、地丁草、草河车、僵蚕草、银珠、姜黄、冰片、蜂房、蝉衣、半枝莲、三七、甘草、连翘、轻粉、青黛、黄蜡等对革兰阴性、阳性菌,对真菌,对病毒均有明显的抑制和杀灭作用,它能帮助病人使褥疮创面的感染得到控制,促进创面地愈合。野菊花、红花、半枝莲、三七、甘草、连翘、青黛、姜黄、草河车、蜂房有明显的抗炎作用,能够抑制毛细血管通透性增高,减少渗出抑制水肿的发展。补骨脂、甘草、半枝莲、三七、蜂房可增强机体免疫功能,增强机体抵抗力,增强机体去腐生肌,消炎散结的能力,达到有促进坏死组织液化脱落,加速新生组织的修复作用。
上述诸药配伍精良,组方合理,共奏解毒消肿、清热透邪、去腐生肌,消炎散结等功效,不仅保护了人体重要器官,促进了坏死组织液化脱落,帮助新生组织迅速原位生长康复。同时也避免了手术和长期用药之苦,为褥疮患者减轻了痛苦,该药系纯中药制剂,疗效确切,安全可靠,无任何毒副作用,药源丰富广泛,价格较低,生产工艺简单,容易操作,对褥疮创面换药,每日一次即可,即经济实用,又减少了病人的痛苦,便于推广应用。
临床效果验证:
选取褥疮患者70例,经全面体检,均无败血症等并发症。其中男30例,女40例,年龄18-80岁。全部病例随机分为治疗组和对照组,每组35例,两组病例在性别,年龄,病情,病程等方面差异无统计学意义(p>0.05),具有可比性。
治疗方法:
1、治疗组:使用生理盐水将褥疮创面洗净,将本发明褥疮膏抹于褥疮创面,每平方米涂抹50g药膏,每天换药一次,七天为一疗程。
2、对照组:使用生理盐水将褥疮创面洗净,在患处涂龙胆紫药水,面积略大于患处,每天换药一次,七天为一疗程。
疗效判断:
治愈:疮面愈合,瘢痕形成;
显效:疮面缩小,褥疮结痂;
有效:疮面缩小、变浅、渗出明显减少;
无效:局部无变化或加重。
疗效结果:
治疗后,治疗组治愈32例,显效2例,有效1例,无效0例,治愈率为91.4%,对照组治愈19例,显效7例,有效4例,无效5例,痊愈率为54.3%。治疗组治愈率明显高于对照组(两组结果相比P<0.01,差异有统计学意义)。详细结果见表1。
表1:两组病例治疗后的疗效对照结果表
| 组别 | 例数 | 治愈n | 显效n | 有效n | 无效n | 治愈率(%) |
| 治疗组 | 35 | 32 | 2 | 1 | 0 | 91.4 |
| 对照组 | 35 | 19 | 7 | 4 | 5 | 54.3 |
结果表明,本发明褥疮膏在疗效上比传统疗法有较大的提高,在临床上有较好的治疗效果;对照组共有8例患者出现副作用,而使用本发明药膏的病人,仅有1例患者出现不良反应,说明本发明药膏毒副作用小。
具体实施方式
实施例1:一种中药褥疮膏,所述褥疮膏包括以下组分:野菊花10g、地丁草10g、草河车10g、红花10g、僵蚕草5g、银珠5g、姜黄5g、补骨脂5g、乳香5g、冰片5g、蜂房3g、蝉衣5g、甘草5g、半枝莲5g、轻粉2g、连翘5g、三七5g、青黛3g、黄蜡30g。
实施例2:一种中药褥疮膏,所述褥疮膏包括以下组分:野菊花12g、地丁草12g、草河车12g、红花12g、僵蚕草7g、银珠7g、姜黄7g、补骨脂7g、乳香7g、冰片7g、蜂房3g、蝉衣7g、甘草7g、半枝莲7g、轻粉3g、连翘7g、三七7g、青黛3g、黄蜡34g。
实施例3:一种中药褥疮膏,所述褥疮膏包括以下组分:野菊花14g、地丁草14g、草河车14g、红花14g、僵蚕草9g、银珠9g、姜黄9g、补骨脂9g、乳香9g、冰片9g、蜂房4g、蝉衣9g、甘草9g、半枝莲9g、轻粉4g、连翘9g、三七9g、青黛4g、中药黄蜡38g。
实施例4:一种褥疮膏,所述褥疮膏包括以下组分:野菊花16g、地丁草16g、草河车16g、红花16g、僵蚕草11g、银珠11g、姜黄11g、补骨脂11g、乳香11g、冰片11g、蜂房5g、蝉衣11g、甘草11g、半枝莲11g、轻粉5g、连翘11g、三七11g、青黛5g、黄蜡42g。
实施例5:一种中药褥疮膏,所述褥疮膏包括以下组分:野菊花18g、地丁草18g、草河车18g、红花18g、僵蚕草13g、银珠13g、姜黄13g、补骨脂13g、乳香13g、冰片13g、蜂房6g、蝉衣13g、甘草13g、半枝莲13g、轻粉6g、连翘13g、三七13g、青黛6g、黄蜡46g。
实施例6:一种中药褥疮膏,所述褥疮膏包括以下组分:野菊花20g、地丁草20g、草河车20g、红花20g、僵蚕草15g、银珠15g、姜黄15g、补骨脂15g、乳香15g、冰片15g、蜂房7g、蝉衣15g、甘草15g、半枝莲15g、轻粉8g、连翘15g、三七15g、青黛7g、黄蜡50g。
此外,上述实施例中所述褥疮膏制备方法为,将蜂腊250g、石腊895g倒入容器中,将上述重量的药物浸入10000毫升色拉油内,浸3天。用文火逐渐加热至沸腾,沸腾30分钟后,停止加热30分钟,此方法再重复循环两次,待药温降至70度左右,用多层消毒纱布滤过,将滤液倒入装有蜂腊、石腊的容器中使之溶解,至药温达到40摄氏度时进行分装,包装可50g-250g/瓶,即可待用。
使用方法:将褥疮创面用0.1%利凡诺尔冲洗消毒,再用生理盐水冲洗创面,创面若有坏死组织可根据情况适当予以剪除,以不出血为度。创面消毒切记冲洗、冲洗、再冲洗。消毒完毕,在创面上覆盖一层消毒纱布,在其上面涂褥疮软膏1-2mm厚度,外用消毒纱布6-8层包裹,再用绷带包扎固定,每日换药一次至痊愈。
典型治愈病例
段某,男,77岁,患者因发生偏瘫,需常年卧床不起,背部,腰部均出现褥疮,多次求治西药无效,使用本发明药膏外敷一周,溃烂停止,红肿开始消退。继续外敷两周后,患处收口愈合,恢复健康。
刘某,女,55岁,患者因车祸而致高位截瘫,卧床半年后患上褥疮,经过现有方法治疗后在骶骨处仍有5-6cm大小的创口一直无法愈合,深度1-2cm,可见骶骨,后采用本发明药膏,敷药一周后,疼痛有所缓解,持续敷药一个月后,患处收口愈合,溃疡深处长出肉芽,继续敷药半个月后痊愈,随访无复发。
宋,男,64岁,患者长年瘫痪在床,背部、腰部大面积褥疮,溃疡处可见髋关节属3级以上褥疮,背部属2级褥疮,患处曾做过植皮手术,但仍无法治愈。在朋友推荐下,病人家属决定使用本发明药膏,使用约两周后髋关节溃疡深处开始长出新的肉芽,1个月后创口痊愈。
Claims (7)
1.一种中药褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花10-20g、地丁草10-20g、草河车10-20g、红花10-20g、僵蚕草5-15g、银珠5-15g、姜黄5-15g、补骨脂5-15g、乳香5-15g、冰片5-15g、蜂房3-7g、蝉衣5-15g、甘草5-15g、半枝莲5-15g、轻粉2-8g、连翘5-15g、三七5-15g、青黛3-7g、黄蜡30-50g。
2.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花10g、地丁草10g、草河车10g、红花10g、僵蚕草5g、银珠5g、姜黄5g、补骨脂5g、乳香5g、冰片5g、蜂房3g、蝉衣5g、甘草5g、半枝莲5g、轻粉2g、连翘5g、三七5g、青黛3g、黄蜡30g。
3.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花12g、地丁草12g、草河车12g、红花12g、僵蚕草7g、银珠7g、姜黄7g、补骨脂7g、乳香7g、冰片7g、蜂房3g、蝉衣7g、甘草7g、半枝莲7g、轻粉3g、连翘7g、三七7g、青黛3g、黄蜡34g。
4.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花14g、地丁草14g、草河车14g、红花14g、僵蚕草9g、银珠9g、姜黄9g、补骨脂9g、乳香9g、冰片9g、蜂房4g、蝉衣9g、甘草9g、半枝莲9g、轻粉4g、连翘9g、三七9g、青黛4g、黄蜡38g。
5.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花16g、地丁草16g、草河车16g、红花16g、僵蚕草11g、银珠11g、姜黄11g、补骨脂11g、乳香11g、冰片11g、蜂房5g、蝉衣11g、甘草11g、半枝莲11g、轻粉5g、连翘11g、三七11g、青黛5g、黄蜡42g。
6.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花18g、地丁草18g、草河车18g、红花18g、僵蚕草13g、银珠13g、姜黄13g、补骨脂13g、乳香13g、冰片13g、蜂房6g、蝉衣13g、甘草13g、半枝莲13g、轻粉6g、连翘13g、三七13g、青黛6g、黄蜡46g。
7.根据权利要求1所述的一种褥疮膏,其特征在于,所述褥疮膏包括以下组分:
野菊花20g、地丁草20g、草河车20g、红花20g、僵蚕草15g、银珠15g、姜黄15g、补骨脂15g、乳香15g、冰片15g、蜂房7g、蝉衣15g、甘草15g、半枝莲15g、轻粉8g、连翘15g、三七15g、青黛7g、黄蜡50g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433552.6A CN104922614A (zh) | 2015-07-22 | 2015-07-22 | 一种中药褥疮膏 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510433552.6A CN104922614A (zh) | 2015-07-22 | 2015-07-22 | 一种中药褥疮膏 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104922614A true CN104922614A (zh) | 2015-09-23 |
Family
ID=54110262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510433552.6A Pending CN104922614A (zh) | 2015-07-22 | 2015-07-22 | 一种中药褥疮膏 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104922614A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421136A (zh) * | 2016-11-10 | 2017-02-22 | 刘大仟 | 一种消炎止痒油 |
| CN110960616A (zh) * | 2019-12-30 | 2020-04-07 | 湖北仟枝生物科技有限公司 | 一种治疗褥疮坏疽的抗菌修护软膏及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091309A (zh) * | 2011-01-25 | 2011-06-15 | 陈晓玲 | 治疗褥疮的药物组合物及其制备方法 |
| CN102475817A (zh) * | 2010-11-25 | 2012-05-30 | 庞昌旭 | 祛腐生肌散及制备方法 |
| CN103356990A (zh) * | 2013-07-17 | 2013-10-23 | 魏可林 | 一种褥疮膏 |
-
2015
- 2015-07-22 CN CN201510433552.6A patent/CN104922614A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102475817A (zh) * | 2010-11-25 | 2012-05-30 | 庞昌旭 | 祛腐生肌散及制备方法 |
| CN102091309A (zh) * | 2011-01-25 | 2011-06-15 | 陈晓玲 | 治疗褥疮的药物组合物及其制备方法 |
| CN103356990A (zh) * | 2013-07-17 | 2013-10-23 | 魏可林 | 一种褥疮膏 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421136A (zh) * | 2016-11-10 | 2017-02-22 | 刘大仟 | 一种消炎止痒油 |
| CN110960616A (zh) * | 2019-12-30 | 2020-04-07 | 湖北仟枝生物科技有限公司 | 一种治疗褥疮坏疽的抗菌修护软膏及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105833279A (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
| CN103230493B (zh) | 一种治疗创口不愈的中药组合物 | |
| CN103356990B (zh) | 一种褥疮膏 | |
| CN103893557A (zh) | 一种治疗褥疮的中药制剂 | |
| CN102335309A (zh) | 一种烧、烫伤药膏的配方 | |
| CN102379996B (zh) | 一种治疗疥疮的外用中药 | |
| CN103845578B (zh) | 治疗烧烫伤、褥疮、带状疱疹外用酊剂及制备方法 | |
| CN102824449B (zh) | 一种治疗褥疮、创口感染、糖尿病皮肤病的外用酊剂 | |
| CN102228623A (zh) | 一种用于治疗烧烫伤的药物组合物及其制备方法 | |
| CN103638316B (zh) | 一种治疗皮炎的中药制剂 | |
| CN102743587A (zh) | 一种外用创伤修复液 | |
| CN107007761B (zh) | 一种中药烧伤油及其制备方法 | |
| CN104107376A (zh) | 一种外用消炎药组方与制作方法 | |
| CN103599234B (zh) | 防治伤口感染的中药药液及其制备方法 | |
| CN102688368B (zh) | 一种用于治疗外伤止血或顽固性溃疡的中药 | |
| CN105362437A (zh) | 一种治疗褥疮药油膏组方及其制备方法 | |
| CN106728069B (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
| CN105250685A (zh) | 一种用于治疗烧伤的中药组合物及其制备方法 | |
| CN102824495B (zh) | 一种临床护理用治疗褥疮的中药膏及其制备方法 | |
| CN104474188A (zh) | 治疗褥疮的中草药药油 | |
| CN103599205B (zh) | 防治伤口感染的中药药液及其制备方法 | |
| CN102813828B (zh) | 治疗外伤的羊角拗药物 | |
| CN102284006A (zh) | 一种治疗褥疮及烧烫创伤的外用膏剂 | |
| CN108245577B (zh) | 一种烧伤止痛消肿生肌液膏及其制备方法 | |
| CN104491327A (zh) | 一种用于治疗褥疮的喷雾药剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150923 |